摘要
目的观察α-硫辛酸、莫沙比利联合治疗糖尿病神经源性膀胱的临床疗效。方法20例2型糖尿病神经源性膀胱患者,予以α-硫辛酸、莫沙比利联合治疗10 d,比较治疗前后B超膀胱残余尿量的变化。结果治疗后B超测定的膀胱残余尿量较治疗前有明显减少(t=14.604,P<0.01)。结论α-硫辛酸、莫沙比利联合治疗糖尿病神经源性膀胱有较好的临床疗效。
Objective The study was designed to assess the role of lipoic acid and Mosapride in treating diabetic neurogenic bladder. Methods Twenty patients with type ：2 diabetes and diabetic neurogenic bladder were treated with lipoic acid and Mosapride for ten days, and the postvoiding residue of bladder measured by ultrasonogram were compared before and after therapy. Resuits The postvoiding residue of bladder after therapy were significantly decreased than those before therapy （t = 14. 604, P 〈 0. 01 ）. Conclusion Lipoic acid and Mosapride can significantly improve the postvoiding residue of bladder in patients with diabetic neurogenic bladder.
出处
《临床医学》
CAS
2009年第3期33-34,共2页
Clinical Medicine
关键词
糖尿病
神经源性膀胱
Α-硫辛酸
莫沙比利
Type 2 diabetes
Diabetic neurogenic bladder
Lipoic acid
Mosapride
